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Antibody-mediated immune responses rely on antigen recognition by the B cell antigen
receptor (BCR) and the proper engagement of its intracellular signal effector proteins. Src
homology (SH) 2 domain-containing leukocyte protein of 65 kDa (SLP65) is the key scaffold
protein mediating BCR signaling. In resting B cells, SLP65 colocalizes with Cbl-interacting
protein of 85 kDa (CIN85) in cytoplasmic granules whose formation is not fully understood.
Here we show that effective B cell activation requires tripartite phase separation of SLP65,
CIN85, and lipid vesicles into droplets via vesicle binding of SLP65 and promiscuous inter-
actions between nine SH3 domains of the trimeric CIN85 and the proline-rich motifs (PRMs)
of SLP65. Vesicles are clustered and the dynamical structure of SLP65 persists in the droplet
phase in vitro. Our results demonstrate that phase separation driven by concerted transient
interactions between scaffold proteins and vesicles is a cellular mechanism to concentrate
and organize signal transducers.
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Ligation of the BCR by cognate antigen results in therecruitment and activation of the cytosolic spleen tyrosinekinase Syk that in turn phosphorylates the enzymatically inert
adapter protein SLP651, also called B cell linker protein (BLNK)2.
Apart from its C-terminal SH2 domain, SLP65 is an intrinsically
disordered protein (IDP)3 that contains multiple tyrosine phos-
phorylation sites and proline-rich motifs (PRMs) to interact in a
specific manner with SH2 and SH3 domain-containing ligands,
respectively4,5. Phosphorylated SLP65 recruits Bruton’s tyrosine
kinase (BTK) and Phospholipase C-γ2 (PLCG2)6–8 to trigger sev-
eral intracellular B cell activation pathways such as mobilization of
the second messenger Ca2+ and nuclear translocation of the pivotal
transcription factor NF-κB9,10. Hence, SLP65 is the signal gate-
keeper of B cell activation. Indeed, loss of SLP65 expression or its
function severely compromises the development and function of B
cells in mice and humans11,12.
More recently, we found that the signaling function of SLP65
relies on its interaction with intracellular vesicles to which it is
attached by virtue of an N-terminal lipid binding moiety13,14. A
majority of these vesicles stained positive for vesicle-associated
membrane protein (VAMP) 7 and quinacrine, but there was
no unique marker or combination of markers characterizing a
particular cellular vesicle pool that specifically attracts SLP65
molecules. However, the vesicular compartmentalization of
SLP65 appeared to be critical for the stimulation-independent (i.e.
constitutive) association of SLP65 with CIN8513,15. The associa-
tion of SLP65 and CIN85 is caused by atypical SH3 domain
docking motifs in SLP65 that associate in a promiscuous manner
with the three N-terminal SH3 domains of CIN8515. A C-
terminal coiled coil domain of CIN85 forms stable CIN85 trimers
that drive multimerization of SLP65. Functional studies showed
that the formation of a permanent SLP65/CIN85 oligomeric
complex in resting B cells is mandatory for proper B cell
activation4,16. In humans, the loss of CIN85 expression causes
severe antibody deficiency caused by B cell-intrinsic signaling
defects, highlighting the non-redundant function of CIN85 for
BCR signal transduction17.
To elucidate how exactly the concerted interactions between
SLP65, CIN85 and vesicles promote B cell activation, we used a
combination of various methods to investigate the structure of
these complexes and their functional signaling role in the live B
cell. Here we show that all three components act in concert to
drive a tripartite liquid-liquid phase separation process in vitro at
physiological protein concentrations. In the live B cell, this results
in the formation of intracellular signaling bodies or droplets that
are reminiscent of other phase-separated organelles such as stress
granules or RNA transport granules18–20.
Results
Tripartite phase separation at physiological concentrations. In
accordance with previously published data13,15, citrine-tagged
wild-type SLP65 but not mutant versions of SLP65 lacking either
the N-terminal lipid binding domain or the CIN85-interacting
PRMs formed submicrometer granules in resting B cells (Fig. 1a).
The subcellular localization patterns strictly correlated with the
ability or disability of SLP65 to trigger mobilization of the second
messenger Ca2+ on BCR ligation (Supplementary Fig. 1). Hence,
the formation of granules through coordinated interactions of
SLP65 with both vesicles and CIN85 appeared requisite for
proper SLP65 signaling as suggested previously13,15. Next, we
investigated by confocal fluorescence microscopy, whether gran-
ule formation can be recapitulated in vitro using recombinantly
expressed SLP65 and CIN85 and synthetic lipid vesicles in dif-
ferent combinations. We found that in the absence of vesicles,
SLP65 undergoes phase separation when mixed with a
monomeric CIN851-333 version lacking the trimerizing C-
terminal coiled coil domain at and above 60 µM concentration
of both proteins (Fig. 1b–c). The threshold concentration for
phase separation was lowered to 10 µM when SLP65 was mixed
with trimeric CIN85Δ57 (Fig. 1d). This CIN85 variant lacking 57
amino acids in the center of the protein was used because full-
length CIN85 could not be recombinantly produced in sufficient
quantities. However, we confirmed the functionality of the
CIN85Δ57 version by reconstitution experiments of CIN85-
deficient B cells (Supplementary Fig. 2). These results showed
that SLP65 and CIN85 can undergo phase separation and that the
phase separation boundary is controlled by their valency, which
was mediated by three and nine SH3 domains of the monomeric
and trimeric CIN85 forms, respectively. The promoting role of
high valency for droplet formation is a common feature of phase-
separating proteins21.
The SLP65/CIN85 droplets formed at and above 10 µM were
about 10 µm in diameter, which is similar to or even larger than
the diameter of the B cell itself. We therefore tested a possible
contribution of vesicles and investigated whether the presence of
small unilamellar vesicles (SUVs) in our in vitro approach would
change the diameter of the droplets and/or lower the protein
concentration needed for initiating the phase separation process.
Indeed, addition of SUVs promoted droplet formation at 20 times
lower protein concentrations, namely 0.5 μM (Fig. 1e). Impor-
tantly, this concentration was similar to the endogenous
concentrations of SLP65 and CIN85 in DG75 and primary
human B cells (Supplementary Fig. 3). Thus, phase separation of
SLP65 and CIN85 occurs in vitro at protein concentrations found
in vivo, but only in the presence of vesicles. This finding was
confirmed further by the increased phase transition threshold of
10 µM for the N-terminal SLP65 deletion mutant, SLP65ΔN
(Fig. 1f), which is unable to attach to vesicles13 and that does
neither support granule formation nor BCR-activated Ca2+
mobilization when expressed in live B cells (see Fig. 1a and
Supplementary Fig. 1). Importantly, no phase separation was
observed when SLP65 was mixed with SUVs in the absence of
CIN85Δ57 (Fig. 1g) demonstrating again the concerted action of
all three components that is needed for droplet formation in vitro.
This finding recapitulated in vivo requirements of droplet
formation and signaling. When SLP65-deficient B cells were
reconstituted with a SLP65 variant that contained Arg-to-Ala
substitutions in two of its PRMs to prevent binding to CIN85,
granules were absent and the Ca2+ flux response was abrogated
(Fig. 1a and Supplementary Fig. 1). Finally, the in vitro-assembled
droplets were 1–2 µm in diameter, which closely resembled that
of the granules observed in live B cells (Fig. 1a, e). Taken together,
these results demonstrated that all three components necessary
for in vitro phase separation are also essential for the proper
subcellular localization and signaling competence of SLP65
in vivo. The vesicular attachment of SLP65 appears to provide
a local seeding point that concentrates SLP65 to facilitate the
recruitment of CIN85 and to initiate phase separation.
SUVs rather than LUVs drive phase separation. To further
elucidate the role of vesicles in promoting droplet formation of
SLP65/CIN85 complexes, we first tested the impact of the vesicle
radius. We generated two types of neutral liposomes composed of
75 mol% 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and
25mol% 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE)
with mean hydrodynamic radii (Rh) of 20 nm and 60 nm, repre-
senting SUVs and large unilamellar vesicles (LUVs), respectively.
Liposomes were mixed with recombinantly produced wild-type
SLP65 and subjected to gradient ultracentrifugation upon which
vesicles floated on the top of the tube. Individual fractions were
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tested for the presence of SLP65 by immunoblotting. This type of
liposome floatation assay revealed a striking binding preference of
SLP65 for SUVs with Rh of 20 nm (Fig. 2a). Furthermore, these
neutral SUVs promoted phase transition of SLP65 and CIN85
with a transition threshold of 1 µM that was similar to that for
negatively charged SUVs containing 30mol% of cholesterol
(Fig. 2b) – a common lipid composition reported for vesicles in
mammalian cells22.
These data showed that the tripartite phase transition is
facilitated by SUVs rather than LUVs, indicating that SLP65
attaches preferentially at small vesicles. Hence, the N-terminal
lipid binding domain of SLP65 appeared to be sensitive to
membrane curvature. To further investigate whether other SUV
binding domains covalently connected to SLP65 would show
phase separation and be functional in B cells, we exchanged the
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Fig. 1 Tripartite phase separation of SLP65 with CIN85 and SUVs. a Confocal fluorescence microscopy of SLP65-deficient DT40 B cells that had been
reconstituted with a citrine fusion protein of either wild-type SLP65 (left), a variant lacking N-terminal 45 amino acids (ΔN, middle), or a CIN85 binding-
deficient variant (ΔPRM, right). b Domain architecture of the different constructs of SLP65 and CIN85 studied here (PRR: proline-rich region, CC: coiled
coil). c–e Confocal fluorescence microscopy of a mixture of different concentrations of Atto 430LS-tagged SLP651-330 with the corresponding equal
concentrations of either (c) CIN851-333, (d) CIN85Δ57, or (e) CIN85Δ57 and SUVs made from 1mM of phospholipids (see Method). The SUVs had a lipid
composition of DOPC:DOPE:DOPS= 65:25:10 mol% and a mean hydrodynamic radius of 23 nm. Concentrations of CIN85Δ57 refer to the monomeric
concentration. Index of dispersion of the fluorescence intensity were shown as box-and-whisker plots (12 ROIs and two independent samples, n= 24). The
line inside the box and the edges of the box correspond to the median, first and third quartiles, respectively. The outliers with value ≥1.5 times the
interquartile range away from the top or bottom of the box are denoted by circles. Source data are provided as a Source Data file. f Different concentrations
of Atto 430LS-tagged SLP6540-330 were mixed with the corresponding equal concentrations of CIN85Δ57 together with 1 mM of SUVs. g Mixture of 5 μM
of Atto 430LS-tagged SLP651-330 and 1 mM of SUVs without CIN85 (left) or with 5 μM of CIN85Δ57 (right). Scale bars equal to 10 μm (a, c–g).
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domain, the N-BAR (Bin-Amphiphysin-Rvs) domain of Amphi-
physin, and expressed the resulting chimeric fusion protein in
SLP65-negative DT40 B cells in order to then test its subcellular
localization and signaling capacity (Fig. 2c–d). The N-BAR
domain was reported to have a pronounced binding preference
for small, i.e. highly curved, vesicles23,24. The chimeric N-BAR-
SLP65ΔN was expressed in SLP65-deficient B cells in similar
amounts and fully restored Ca2+ mobilization to wild-type level
(Fig. 2c). The signaling-competent N-BAR-SLP65ΔN protein also
formed dot-like speckles (Fig. 2d) that were reminiscent of those
observed for wild-type SLP65 granules (see above). Furthermore,
N-BAR-SLP65ΔN translocated to sites of BCR activation at the
plasma membrane following BCR ligation (Fig. 2d). Collectively,
these data showed that the N-terminal lipid binding domain
preferentially attaches at small vesicles with curved membranes
and that this feature allows for tripartite phase separation at
physiological concentrations, i.e. in vitro as well as in vivo.
Vesicle clustering in the droplet phase revealed by cryo-ET.
Since SUVs are required for SLP65 and CIN85Δ57 to phase-
separate at their physiological concentrations, we sought to
investigate the ultrastructural organization within the droplets by
cryo-electron tomography (cryo-ET) and assess their distribution
in the in vitro phase-separated samples (Fig. 3a). The cryo-ET
data showed that while the center is tightly packed, the vesicle
concentration drops quickly toward the phase border. Further-
more, the tomograms showed a stochastic distribution of SUVs
inside the droplets and an average surface-to-surface distance of
5 nm (Fig. 3b). The radius of vesicles within the phase-separated
compartment was found to be 9.10 ± 0.03 nm (Fig. 3c). Taken
together, the tomography data therefore supports the idea that
formation of the droplets is driven by tripartite phase separation
between SLP65, CIN85, and highly curved vesicles.
SLP65 is 10-fold enriched in the droplet phase. We also char-
acterized phase-separated SLP65/CIN85 droplets and assessed
how strongly SLP65 is enriched in the droplet phase by quanti-
fication of its partition coefficients using the fluorescence inten-
sity (Supplementary Fig. 4). This approach revealed that in the
absence of SUVs, concentration of SLP65 in the droplet phase
was found to be three to ten times higher than in the dispersed
phase. Despite the moderate difference in concentration, distinct
spherical liquid phases were also observable by bright-field ima-
ging (Supplementary Fig. 5). Importantly, the addition of SUVs
resulted in an augmented ten-fold enrichment of SLP65 when
mixed at the transition threshold concentration of 0.5 μM, and
the partition coefficient further increased with higher con-
centrations of SLP65 and CIN85Δ57 (Supplementary Fig. 4).
These data further emphasize the importance of SUVs in the
formation of phase-separated SLP65/CIN85 signaling complexes.
Phase-separated SLP65 retains dynamic flexibility. Finally, we
also characterized phase-separated SLP65 by NMR spectroscopy
to gain structural insight at the atomic level. The sharp peaks
observed in the 15N-HSQC (heteronuclear single quantum
coherence) spectrum of SLP65 are typical for IDPs, implying fast
reorientation motion of protein segments. Compared to SLP65
alone, phase-separated SLP65 induced by the addition of either
CIN851-333, CIN85Δ57, or CIN85Δ57 and SUVs exhibited similarly
sharp peaks, as exemplified by the almost equal peak intensity for
residues away from the binding sites (Fig. 4a–c) as well as the 15N
relaxation data (Supplementary Fig. 6). These results showed that





































































Fig. 2 Phase separation modulated by vesicle curvature and lipid composition. a A mixture of recombinant SLP65 with either SUVs (Rh≈ 20 nm) or
LUVs (Rh≈ 60 nm) was fractionated by a sucrose gradient flotation assay, and the different layers were subjected to anti-SLP65 immunoblot analysis
(apparent MW indicated in kDa). Vesicles will float to the top and are found in layers 1 and 2. Bar graph shows the percentage of SLP65 associated with
vesicles based on the immunoblot signal intensity. b Confocal fluorescence microscopy of a mixture of different concentrations of Atto 430LS-tagged
SLP651-330 and CIN85Δ57 together with SUVs containing DOPC:DOPE of 75:25mol% (b, top) and DOPC:DOPE:DOPS:cholesterol of 35:25:10:30mol%
(b, bottom), respectively. (Scale bar= 10 μm) Source data are provided as a Source Data file. c SLP65-deficient DT40 B cells were transduced with
constructs encoding citrine-tagged SLP65ΔN fusion proteins with the N-BAR domain of Amphiphysin. Wild-type SLP65 and SLP65ΔN-expressing cells
served as positive and negative controls, respectively. The domain structures of the expressed SLP65 variants are depicted in the upper part of (c). Cells
were loaded with the Ca2+-sensitive fluorophore Indo-1 and Ca2+ flux was monitored by flow cytometry. Cells were stimulated with anti-BCR antibody
(M4) at the indicated time point. d Confocal fluorescence microscopy of cells transduced with N-BAR-SLP65ΔN were either left untreated (upper panel) or
stimulated via their BCR (lower panel).
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fluidity is completely preserved in phase-separated SLP65 in the
absence, as well as in the presence of vesicles. Hence, functionally
relevant motifs within SLP65, e.g. tyrosine phosphorylation sites,
are equally well accessible under both conditions. Indeed, Syk-
phosphorylated SLP65 retains its potential to phase-separate with
CIN85 and SUVs. (Supplementary Fig. 7). Accordingly, the five
tyrosine phosphorylation sites are not involved in the binding to
CIN85’s SH3 domains and therefore not expected to interfere
with the SLP65/CIN85 interaction.
For the mixtures containing SUVs, the observed 10% signal
loss in the NMR spectra (Fig. 4c, depicted in green and cyan) was
due to fractions of SLP65 interacting with SUVs that rotate much
slower and did not depend on phase separation, i.e. on the
presence or absence of CIN85Δ57. Backbone dynamics of SLP65
was not affected significantly by phase separation due to the
relatively low partition coefficients (Supplementary Fig. 4). When
concentrations of SLP65 and CIN851-333 were increased from 120
μM to 2400 μM, the 15N lines were broadened by 1.7-fold only
(Supplementary Fig. 6), indicating a modest increase in viscosity
upon a substantial increase in protein concentration. This is in
line with the NMR studies on phase-separated FUS LC25 and
Ddx426 that revealed fluidity reduction by a factor of 4–6 when
concentrations were increased by 50 to 140-fold. In addition to
the dynamics, chemical shifts of the majority of the peaks were
also unchanged (Fig. 4a). Taken together, phase separation
concentrates SLP65 without altering its dynamic structure,
particularly the regions surrounding the tyrosine phosphorylation
sites that bind downstream effectors.
Multivalent SH3 domain-mediated interactions have been
shown to drive protein phase separation21. CIN85’s SH3 domains
bind to multiple PRMs on SLP65 with different affinities
(Fig. 4c–d). Amide resonance peaks of the first three PRMs (i.e.
V47, A115, and V164) were shifted progressively in the titration
series, indicating fast exchange between bound and unbound
forms (Fig. 4d, left). Conversely, the peaks of the last three PRMs
(i.e. S243, E279, and R312) were broadened beyond detection,
which is indicative of tighter bindings (Fig. 4d, right). At 15 μM
concentrations of SLP65 and CIN85Δ57, where phase separation
has already occurred, only the high-affinity PRMs were involved
in the interactions (Fig. 4c, depicted in orange and cyan). These
data suggest that at low concentrations of SLP65 and CIN85, the
high-affinity PRMs are the major interaction sites that drive
phase separation in vivo, while the others remain accessible to
different binding partners of SLP65. To investigate their binding
specificity, we used paramagnetic relaxation enhancement to
probe the interactions between a targeted PRM of SLP65 and the
three SH3 domains of CIN85. The paramagnetic relaxation data
indicate that all SH3 domains bind to the strongly interacting
PRMs in a promiscuous manner (Supplementary Fig. 8),
minimizing entropy loss when the droplet phase forms21. In
summary, these data showed that the structural parameters of the
interaction between SLP65 and CIN85 obey to those found for
other phase-separating entities.
Discussion
Liquid-liquid phase separation of proteins and RNA18–20 has been
reported to underlie the formation of various functionally impor-
tant nuclear and cytoplasmic membrane-less organelles27–31. The
tripartite phase separation of B-lymphoid signaling elements
described here represents a concept in BCR signal orchestration,
which is unique for several reasons. First, at physiological con-
centrations, both proteins and vesicles are essential for phase
separation. This concerted action is different from the recently
described synaptic vesicles recruitment to already phase-separated
Synapsin 132. Second, phase separation of SLP65 and CIN85 on the
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Fig. 3 Cryo-electron tomogram of the tripartite droplets. a A mixture of 1 μM of SLP651-330 and 1 μM of CIN85Δ57 together with 1 mM of SUVs was placed
on a carbon grid and plunged frozen after incubation. The droplet shows a clear increase in concentration of vesicles toward its center with a steep fall-off
at the edges. Golden spheres represent vesicles that were manually segmented for 3D-visualization in AMIRA 6.2 and processed using an in-house
python script and Matlab. b Histogram of distances between vesicles with an average vesicle to vesicle distance of 4.92 ± 0.1 nm (mean ± SEM; n= 2349).
c Histogram of the vesicle’s radii with a mean radius of 9.10 ± 0.03 nm (mean ± SEM; n= 1718). Source data are provided as a Source Data file.
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the transmembraneous proteins Linker for Activation of T cells
(LAT)33 and Nephrin34 at the relatively flat plasma membrane.
Third, SLP65 has a rather low partition coefficient in the tripartite
system compared to other phase-separating proteins studied so far.
The partition coefficient may depend on several factors including
the type, valency, and strength of the interactions involved. Indeed,
the fluidity of SLP65 is reduced only marginally in the phase-
separated state to participate in dynamic signal processes. Quali-
tatively, the mean distance between the vesicles of 5 nm and even
the most extreme distance of 20 nm measured by cryo-ET fall
within the estimated lengths of two intrinsically disordered SLP65
molecules, each bound to different vesicles and held together by
CIN85 molecules. Although vesicles co-phase separate together with
SLP65 and CIN85 in vitro and our results demonstrate a strong
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Fig. 4 Structural properties of phase-separated SLP65 and its interactions with CIN85. a 15N-HSQC spectra of 60 µM or 15 µM of 15N-labeled SLP65
only (black) were overlaid by the spectra of SLP65 after addition of unlabeled CIN851-333 (pink), CIN85Δ57 (orange), SUVs (green), or SUVs and CIN85Δ57
(cyan) at the indicated concentrations. b Bright field images of the respective NMR samples denoted by colored boxes. (Scale bar= 10 µm) c Residue-
specific peak intensity ratio of the 15N-HSQC spectra shown in a of SLP65 with CIN851-333 (pink), CIN85Δ57 (orange), SUVs (green), or SUVs and
CIN85Δ57 (cyan) over SLP65 only at the corresponding concentrations. Error bar indicates uncertainty propagated from the peak’s signal-to-noise. Proline
residues were marked in red on top of the chart, while PRMs that interact with CIN85 were highlighted with their sequences written. The five tyrosine
residues that are phosphorylated by Syk (Y72, Y84, Y96, Y178, and Y189) were pointed out by inverted triangle. Source data are provided as a Source Data
file. d Zoomed-in regions of 15N-HSQC spectra of 60 µM SLP65 titrated with increasing amounts of CIN851-333 were overlaid to show either shifting or
disappearance of the respective peaks associated with different PRMs.
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correlation between the phase separation transition threshold
in vitro and the granules formation in B cell, it will be important to
further investigate the vesicle distribution in the granules within the
B cell by in situ approaches. Nevertheless, vesicle-driven self-orga-
nization of signal transducing elements into granules has not been
described before as a mode of subcellular compartmentalization.
Signal transducers often have a modular architecture where
multiple interaction domains are flexibly linked and thus
can integrate inputs from different proteins to tune their
signals. Meanwhile, multivalency and structural disorder are also
properties that can promote their phase separation, as shown
here19–21,31. Hence, phase transition may be an additional
mechanism that allows even more robust spatial and temporal
control of signal transduction. The engagement of preformed
signaling microclusters enables their rapid engagement by ligated
cell surface receptors in contrast to recruiting signal effectors in a
stepwise manner. In fact, high receptor signal sensitivity is par-
ticularly needed for extracellular ligands at low concentrations,
e.g. pathogens or hormones. The organization of functionally
related signaling components into distinct subcellular compart-
ments is likely to contribute to signal specificity, a phenomenon
that is still enigmatic. It is conceivable that besides SLP65 and
CIN85, additional BCR-controlled effectors are recruited to the
granules in a dynamic manner. Future experiments on the
ultrastructure, composition and transport of the vesicular signal
granules are needed to address these fundamental aspects of
receptor biology.
Methods
Sample preparations for in vitro experiments. SLP651–330, SLP6540–330, and
CIN851–333 were expressed in Escherichia coli strain BL21(DE3) (New England
Biolabs) as fusion proteins with N-terminal His7-tag. The proteins were first
purified by metal affinity chromatography (Protino Ni-NTA, Macherey Nagel).
The His7-tag was removed by proteolytic cleavage with TEV protease and the
proteins were finally purified by size exclusion chromatography on a HiLoad 16/60
SD 75 gel filtration column (GE Healthcare). The mutants SLP6540–330 (C271A),
SLP6540–330 (C271A, S141C), SLP6540–330 (C271A, S236C), SLP6540–330 (C271A,
Q302C), SLP6540–330 (C271A, R247A, S236C) and SLP6540–330 (R280A) were all
generated by PCR-based mutagenesis (Quikchange II, Agilent). The DNA fragment
coding for CIN85Δ57 (deletion of residues 369-425) was made by overlap extension
PCR using the primers 5′-GCGTCTAGAGGATCCATGGTGGAGGCCATAGTG
GAG-3′, 5′-GTC CTC GAG GAA TTC TCA TTT TGA TTG TAG AGC TTT CTT
TAT GTC G-3′, 5′-GTG TGT GTC AGC GGA CCC ACT CTT TCA GGA GGT
ATC TTT TTA ATT TCA TG-3′, and 5′-CAT GAA ATT AAA AAG ATA CCT
CCT GAA AGA GTG GGT CCG CTG ACA CAC AC-3′ and cloned into a
modified pET28a vector (Novagen). Protein expression and purification was per-
formed as described above. Protein samples of different SLP65 and CIN85 con-
structs were finally transferred by dialysis into buffer containing 20 mM HEPES,
pH 7.2, 100 mM NaCl, 1 mM TCEP, and 0.5 mM Pefabloc.
Atto 430LS dye (Atto-Tec) was conjugated to either SLP651-330 or SLP6540–330
at residue C271 via maleimide thiol reaction. After 2-h incubation, unbound dye
was removed by size exclusion chromatography (Superdex 75 10/300 GL). The
final protein concentration was determined by UV absorbance at 280 nm, taking
into account the dye’s maximum absorbance at 430 nm and its relative absorbance
at 280 nm.
To prepare the vesicles, a total molar concentration of 5 mM phospholipids
with the different phospholipid compositions (Avanti Polar Lipids) was mixed in
chloroform, dried under nitrogen stream, and lyophilized overnight. The lipid film
was then resuspended in the HEPES buffer, sonicated extensively, and extruded
through 50-nm and 100-nm filters (Avanti Polar Lipids) to make 20-nm SUVs and
60-nm LUVs, respectively. The vesicle solution was diluted to a final phospholipids
concentration of 1 mM for the in vitro reconstitution experiments. The
hydrodynamic radius was determined by dynamic light scattering (Wyatt
Technology).
Confocal fluorescence microscopy. Atto 430LS-tagged SLP651–330, CIN851–333 or
CIN85Δ57, and SUVs were mixed at the indicated concentrations in a 20-μl volume,
incubated at room temperature for over 1 h, and then transferred to uncoated 8-
well μ-Slide (ibidi) for microscopy. Confocal fluorescence and bright-field micro-
scopy were performed using Leica TCS SP5 microscope with a water immersion
objective (Leica HCX PL APO CS 63 × /1.20). Atto 430LS-tagged SLP651–330 was
illuminated by 458-nm laser (5 to 20% transmitted power) and observed within the
bandwidth of 500–600 nm. Bright-field imaging was performed using 2% laser
power of 488 nm and observed via a bright-field filter. The images were acquired at
400 Hz without line averaging. For live-cell imaging, cells were resuspended in
serum-free buffer and seeded in glass-covered dishes. Images were recorded using a
Leica TCS SP2 LSM. Fluorescence images were analyzed using ImageJ. The single
side dimension of each region of interest (ROI) was either 61.63 μm (for SLP65’s
concentration ≥ 5 μM) or 20.54 μm (for SLP65’s concentration <2 μM). The pixel
size was either 481.5 nm or 160.5 nm, respectively. To quantify fluorescence
intensities inside and outside of the droplets, first the “Threshold” function was
applied using default algorithm, and then a mask for the droplets was generated
from the binary image using the “Analyze Particles” function. The “Size” parameter
had to be adjusted to include all visually distinguishable droplets and the “Circu-
larity” parameter was set as 0.1–1.0. Index of dispersion (i.e. ratio of intensity
variance to mean) and partition coefficient (i.e. ratio of intensity inside to outside
of droplets) were calculated by Matlab scripts.
Cells and expression vectors and antibodies. DG75 B cells (DSMZ ACC83) were
cultured in RPMI 1640 supplemented with 10% fetal calf serum, 3 mM L-gluta-
mine, 1 mM sodium pyruvate, 50 µM 2-mercaptoethanol and antibiotics. DT40
cells (ATCC CRL-2111) were cultured in medium containing 1% chicken serum
and no pyruvate. BCR stimulation of the cells was performed with 0.5 µg/ml of F
(ab’)2-anti-human IgM (Jackson ImmunoResearch) at 37 °C or 2 µg/ml anti-
chicken-IgM (clone M4; Southern Biotechnology) at room temperature.
The cDNAs encoding human CIN85 and SLP65, respectively, were cloned into the
pMSCV vector (BD Biosciences) containing the sequence for the EGFP variant
citrine, resulting in N-terminal citrine-tagged proteins. In addition to the wild-type
protein-encoding constructs, similar cloning was performed to express variants. The
CIN85-Δ57 variant lacks amino acid residues 369–425, CIN85-ΔCC the amino acid
residues 594–665, SLP65ΔN amino acids 1–45, and SLP65ΔPRM harbors R-to-A
exchanges as described previously4. To express the N-BAR-SLP65ΔN chimeric protein,
construct encoding the amino acid residues 2–239 of murine Amphiphysin N-




CCAGGCGCCGCGTGAA-3′. Empty EGFP encoding vector served as the control.
The resulting expression plasmids were transduced into the CIN85-deficient DG75 B
cells and SLP65-deficient DT40 cells, respectively. Transduced cells were subsequently
subjected to Western Blot, Ca2+ flux, or imaging analyses. Utilized antibodies were
diluted 1:1000 and are specific for SLP65 (clone 2B11, Santa Cruz Biotechnology sc-
8003), CIN85 (clone D1A4, Cell Signalling Technology 12304), CD2AP (R&D
Systems AF4474), or actin (clone 13E5, Cell Signalling Technology 4970). Cytosolic
Ca2+ concentrations were monitored by flow cytometric analysis of cells that were
loaded with 1 µM Indo1-AM (Thermo)3.
Cryo-electron tomography. Sample preparation: for cryo-ET experiments, pro-
teins (1 μM SLP651–330 and 1 μM CIN85Δ57) and SUVs (1mM) were mixed in
an Eppendorf tube and incubated for 45min. In all, 4 µL of said suspension
were carefully applied to R2/1 copper TEM grids (Quantifoil), which were subse-
quently plunge frozen on a Vitrobot Mark IV (FEI, settings: blot force= 10, blot
time= 10 s, temperature= 21 °C, humidity= 90%). The samples were stored under
LN2 until use. Vesicle diameters are not changed by the preparation procedure35.
Data acquisition: the grids were screened for sites suitable for cryo-ET in low
magnification and areas were chosen that still allowed for data acquisition at
reasonable exposure timings (thickness <200–300 nm). Cryo tomograms were
obtained on a transmission electron microscope (Titan Krios, FEG 300 kV, FEI)
with a post-column energy-filter (968 Quantum K2, Gatan) using a defocus range
of −5 to −3.5 µm and an EFTEM magnification of ×42,000 (calibrated pixel size
3.42 Å). Images were recorded with a direct electron detector camera (K2 Summit,
Gatan) in dose-fractionation mode and a total dose of ~80 e−/Å2 per tomogram
using SerialEM36. The acquisition was controlled by an in-house script using a
dose-symmetric tilt scheme37 with an angle increment of 2°. The stage was tilted
between 60° and −60° starting at 0°. Frames were aligned using MotionCor238, and
tomogram reconstruction was performed in IMOD39.
Visualization: to enhanced contrast of the TEM insets, summed projections of
five slices each are shown. Vesicles were manually segmented for 3D-visualization
in AMIRA 6.2 (ThermoFisher) and processed using an in-house python script and
Matlab (Mathworks).
NMR spectroscopy. 15N-labeled SLP651-330 and CIN851-333 were expressed in
M9 minimal medium supplemented with 15N-NH4Cl as nitrogen source. Protein
expression and purification was performed as described above. The samples
were finally transferred by dialysis into buffer containing 20 mM HEPES, pH 7.2,
100 mM NaCl, 1 mM TCEP, and 0.5 mM Pefabloc. In total, 4% D2O and 0.5 mM
DSS were added as internal reference and the samples were kept inside 3-mm
Shigemi or normal NMR tubes.
For PRE measurements, either SLP6540-330 that naturally contains a single
cysteine (C271), or other individual cysteine mutants on the SLP6540-330
(C271A) construct (see above) were ligated with the nitroxide spin label MTSL
(1-oxy-2,2,5,5-tetramethyl-d-pyrroline-3-methyl)-methanethiosulfonate
(Toronto Research Chemicals, Toronto)40.
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All NMR measurements were performed at 293 K on Bruker’s 800MHz and
900MHz spectrometer that are equipped with a z-gradient cryoprobe. The
sensitivity-enhanced 15N-HSQC with water-flipback pulses were measured with a
recycle delay of 1 s and indirect-dimension tmax of 55–70 ms (NS= 8–140, cosine-
squared function in both dimensions). The residue-specific 15N transverse cross-
correlated relaxation rates were measured using 2D TRACT experiment15,41 with
variable delays (NS= 8–80, cosine-squared function in both dimensions) and fitted
to single exponential decay. The 1H R2-PRE was measured on 15N-labeled CIN851-
333 mixed with MTSL-tagged SLP65 constructs at 10:1 molar ratio using a two-
point delay (Δt= 7 ms) in the first INEPT period of a TROSY experiment42 (NS=
64–80, cosine-squared function in both dimensions) and analyzing the peak
intensities. The corresponding SLP65 constructs without MTSL were used as
diamagnetic reference in the presence of 1 mM TCEP.
Data availability
Data supporting the findings of this manuscript are available from the corresponding
authors upon reasonable request. A reporting summary for this Article is available as
a Supplementary Information file. The source data underlying Figs. 1c–e, 2b, 3b, c, 4c,
and Supplementary Figs. 1, 2, 3, 4, 6b, d, and 7 are provided as a Source Data file.
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